Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Clinical trial NCT07366801 · RECRUITING

Trial details

NCT number: NCT07366801
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, Relapsed Acute Lymphoblastic Leukemia, High Risk Acute Myeloid Leukemia, High Risk Acute Lymphoblastic Leukemia, Relapse

Start date: 2025-09-03
Primary completion: 2027-06-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.